[Proper usage of procalcitonin]

Area of Science:

• Clinical diagnostics
• Infectious disease management
• Biomarker research

Background:

• Procalcitonin (PCT) has been studied for 15 years as a diagnostic marker for infection.
• Its use is widespread in febrile patients, but evidence for this broad application is limited.
• PCT is established in intensive care for diagnosing septic shock, prognosis, and guiding antibiotic therapy duration.

Purpose of the Study:

• To evaluate the role of procalcitonin as a diagnostic aid for suspected infections.
• To assess the efficacy of procalcitonin in non-intensive care settings, specifically emergency departments.
• To determine appropriate clinical scenarios for procalcitonin measurement.

Main Methods:

• Review of studies evaluating procalcitonin measurement for suspected infections.
• Analysis of procalcitonin's effectiveness in intensive care versus non-intensive care settings.
• Assessment of procalcitonin's utility in emergency department patients with lower respiratory tract infections and acute febrile illness.

Main Results:

• Procalcitonin is effective in intensive care for diagnosing septic shock, prognosis, and tailoring antibiotic treatment.
• Studies in non-intensive care settings, like the emergency department, show encouraging but preliminary results.
• Evidence for widespread use in all febrile patients is lacking.

Conclusions:

• Procalcitonin is a valuable tool in intensive care for managing severe infections.
• Further research is needed to support the use of procalcitonin in broader, non-intensive care settings.
• Current recommendations suggest restricting procalcitonin measurement to patients with severe infection criteria.